This week in Britain, a landmark historical move to ban puberty blockers in gender clinics has been motioned and overseen by the National Health Service of England (NHS). They will no longer be prescribed to children at gender clinics.
These are drugs used to delay the onset of puberty in adolescent children typically administered to individuals who identify as LGBT and wish to transform their biological gender.
Already a subscriber? Log in
Black Friday sale
Subscribe today and get 10 weeks of The Spectator Australia for just $1
- Unlimited access to spectator.com.au and app
- The weekly edition on the Spectator Australia app
- Spectator podcasts and newsletters
- Full access to spectator.co.uk
Or
Comments
Black Friday sale
Subscribe today and get 10 weeks of The Spectator Australia for just $1
SUBSCRIBEAlready a subscriber? Log in